These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7522041)

  • 1. Correlation of loss of heterozygosity at 11p with tumour progression and survival in non-small cell lung cancer.
    Fong KM; Zimmerman PV; Smith PJ
    Genes Chromosomes Cancer; 1994 Jul; 10(3):183-9. PubMed ID: 7522041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microsatellite alterations at 5q21, 11p13, and 11p15.5 do not predict survival in non-small cell lung cancer.
    Sánchez-Céspedes M; Rosell R; Pifarré A; López-Cabrerizo MP; Barnadas A; Sánchez JJ; Lorenzo JC; Abad A; Monzó M; Navas-Palacios JJ
    Clin Cancer Res; 1997 Jul; 3(7):1229-35. PubMed ID: 9815804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allelic deletion at chromosome 11p13 defines a tumour suppressor region between the catalase gene and D11S935 in human non-small cell lung carcinoma.
    Shipman R; Schraml P; Colombi M; Ludwig CU
    Int J Oncol; 1998 Jan; 12(1):107-11. PubMed ID: 9454893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathologic correlates of loss of heterozygosity in Wilm's tumor: a preliminary analysis.
    Grundy P; Telzerow P; Moksness J; Breslow NE
    Med Pediatr Oncol; 1996 Nov; 27(5):429-33. PubMed ID: 8926924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allelic loss on the short arm of chromosome 11 in non-small-cell lung cancer.
    Ludwig CU; Raefle G; Dalquen P; Stulz P; Stahel R; Obrecht JP
    Int J Cancer; 1991 Nov; 49(5):661-5. PubMed ID: 1682278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of heterozygosity at 11p13 in Wilms' tumours does not necessarily involve mutations in the WT1 gene.
    Cowell JK; Groves N; Baird P
    Br J Cancer; 1993 Jun; 67(6):1259-61. PubMed ID: 8390282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deletion of WT1 and WIT1 genes and loss of heterozygosity on chromosome 11p in Wilms tumors in Japan.
    Kaneko Y; Takeda O; Homma C; Maseki N; Miyoshi H; Tsunematsu Y; Williams BG; Saunders GF; Sakurai M
    Jpn J Cancer Res; 1993 Jun; 84(6):616-24. PubMed ID: 8393432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletion mapping of chromosome 11 in carcinoma of the bladder.
    Shaw ME; Knowles MA
    Genes Chromosomes Cancer; 1995 May; 13(1):1-8. PubMed ID: 7541638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-density marker analysis of 11p15.5 in non-small cell lung carcinomas reveals allelic deletion of one shared and one distinct region when compared to breast carcinomas.
    Tran YK; Newsham IF
    Cancer Res; 1996 Jul; 56(13):2916-21. PubMed ID: 8674040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three non-overlapping regions of chromosome arm 11p allele loss identified in infantile tumors of adrenal and liver.
    Byrne JA; Simms LA; Little MH; Algar EM; Smith PJ
    Genes Chromosomes Cancer; 1993 Oct; 8(2):104-11. PubMed ID: 7504513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of heterozygosity mapping in Wilms tumor indicates the involvement of three distinct regions and a limited role for nondisjunction or mitotic recombination.
    Coppes MJ; Bonetta L; Huang A; Hoban P; Chilton-MacNeill S; Campbell CE; Weksberg R; Yeger H; Reeve AE; Williams BR
    Genes Chromosomes Cancer; 1992 Nov; 5(4):326-34. PubMed ID: 1283321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of heterozygosity on chromosome 11p13 in primary bladder carcinoma.
    Shipman R; Schraml P; Colombi M; Raefle G; Ludwig CU
    Hum Genet; 1993 Jun; 91(5):455-8. PubMed ID: 8100210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microdissecting the genetic events in nephrogenic rests and Wilms' tumor development.
    Charles AK; Brown KW; Berry PJ
    Am J Pathol; 1998 Sep; 153(3):991-1000. PubMed ID: 9736048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of heterozygosity at 9p23 defines a novel locus in non-small cell lung cancer.
    Neville EM; Stewart M; Myskow M; Donnelly RJ; Field JK
    Oncogene; 1995 Aug; 11(3):581-5. PubMed ID: 7630642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 17p13 (p53 locus), 5q21 (APC locus) and 9p21 (p16 locus) allelic deletions are frequently found in oral exfoliative cytology cells from smoker patients with non-small-cell lung cancer.
    Sanz-Ortega J; Roig F; Al-Mousa MM; Saez MC; Muñoz A; Sanz-Esponera J; Callol L
    Histol Histopathol; 2007 May; 22(5):541-5. PubMed ID: 17330809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three tumor-suppressor regions on chromosome 11p identified by high-resolution deletion mapping in human non-small-cell lung cancer.
    Bepler G; Garcia-Blanco MA
    Proc Natl Acad Sci U S A; 1994 Jun; 91(12):5513-7. PubMed ID: 8202519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosomal localisation of two putative 11p oncosuppressor genes involved in human ovarian tumours.
    Viel A; Giannini F; Tumiotto L; Sopracordevole F; Visentin MC; Boiocchi M
    Br J Cancer; 1992 Dec; 66(6):1030-6. PubMed ID: 1360809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency and timing of loss of imprinting at 11p13 and 11p15 in Wilms' tumor development.
    Brown KW; Power F; Moore B; Charles AK; Malik KT
    Mol Cancer Res; 2008 Jul; 6(7):1114-23. PubMed ID: 18644976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosomal 11 alterations in non-small-cell lung carcinomas in Hong Kong.
    Chan AS; Lam WK; Wong MP; Fu KH; Lee J; Yew WW; Chiu SW; Lung ML
    Lung Cancer; 1996 Aug; 15(1):51-65. PubMed ID: 8865123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of heterozygosity frequently affects chromosome 17q in non-small cell lung cancer.
    Fong KM; Kida Y; Zimmerman PV; Ikenaga M; Smith PJ
    Cancer Res; 1995 Oct; 55(19):4268-72. PubMed ID: 7671234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.